Fellowship, Harvard University - Neuroimmunology
Fellowship, University of Rochester, NY - Medical Education
Residency, Loyola University - Neurology
MD, University of La Plata, Argentina
Dr. Miravalle is an Associate Professor of Clinical Neurology at the University of Colorado. He provides care to patients at Advanced Neurology of Colorado. Dr. Miravalle is a board-certified neurologist who sub-specializes in Multiple Sclerosis. Dr. Miravalle received his Medical Degree from the University of La Plata, Argentina. He completed his Neurology Residency training at Loyola University, Chicago. He subsequently completed a Neuroimmunology Fellowship at Harvard University in Boston and a Fellowship in Medical Education at the University of Rochester, New York. Dr. Miravalle has been involved in both clinical and science-based research in the field of Multiple Sclerosis and Neuroimmunology and most recently Dementias.
Rempe T, Wang Q, Reddy V, Newcomer Z, Miravalle A, Mao-Draayer Y, PML and GCN with novel mutation flanking VP1 C-terminus in natalizumab extended interval dosing. Neurology: Neuroimmunology & Neuroinflammation. January 29, 2020
Prosperini L, Kinkel RP, Miravalle A, et al. Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysis. Ther Adv Neurol Disord. Mar 29, 2019
Honce JS, Miravalle A, et al. Rituximab vs placebo induction prior to glatiramer acetate monotherapy in multiple sclerosis. Neurology January 11, 2019
Aleksandar Blubaum A, Blakely S, Westfall N, Miravalle A, Flynn B. Severity of Lower Urinary Tract Symptoms predict overall neurologic quality of life among patients with MS. The Journal of Urology. 2017 Volume 197, Issue 4, Supplement, Pages e1152–e1153
Korb PJ, Miravalle A.Coding in Multiple Sclerosis and Other Demyelinating Diseases. Continuum (Minneap Minn). 2016 Jun;22(3):951-9.